SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ: BSDM) (the “Company” or “BSD”) announced today that the Cancer Treatment Centers of America (CTCA) at Midwestern Regional Medical Center has purchased a BSD-500 Hyperthermia System (BSD-500). CTCA Midwestern Regional Medical Center, located in the metropolitan Chicago area, is a premier cancer care facility that provides the most advanced therapeutic resources in cancer treatment in one location (http://www.cancercenter.com/midwestern-hospital.cfm). CTCA is a network of hospitals that provides an unprecedented level of care to cancer patients, and this will be the sixth BSD Hyperthermia system purchased by CTCA. The CTCA hospitals were recently recognized by the Commission on Cancer of the American College of Surgeons as “offering the very best in cancer care.”
